Cargando…
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
Parkinson’s disease (PD) is characterized by motor symptoms, such as resting tremor, bradykinesia and rigidity, but also features non-motor complications. PD patients taking dopaminergic therapy, such as levodopa but especially dopamine agonists (DAs), evidence an increase in impulse control disorde...
Autores principales: | Yang, Xue Qing, Glizer, Daniel, Vo, Andrew, Seergobin, Ken N., MacDonald, Penny A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067488/ https://www.ncbi.nlm.nih.gov/pubmed/27803657 http://dx.doi.org/10.3389/fnhum.2016.00523 |
Ejemplares similares
-
Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
por: Yang, Xue Q., et al.
Publicado: (2018) -
Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
por: Gallant, Haley, et al.
Publicado: (2016) -
Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease
por: Vo, Andrew, et al.
Publicado: (2014) -
Error-related negativity and error awareness in a Go/No-go task
por: Wang, Lijun, et al.
Publicado: (2020) -
Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014
por: Glizer, Daniel, et al.
Publicado: (2016)